Type 2 diabetes
Conditions
Interventions
control group:NA
treatment group :NA
Sponsors
Guang'anmen Hospital, China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1) Patients who sign the informed consent form. 2) patients who meet the diagnostic criteria for type 2 diabetes from Professor Tong Xiaolin's outpatient and endocrine outpatient, according to the 2011 World Health Organization (WHO) diagnostic criteria.
Exclusion criteria
Exclusion criteria: 1) Patients without telephone contact information. 2) Patients who do not cooperate with the questionnaire.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cardiovascular events: number of myocardial infarction, stent implantation, heart failure, death;Cerebrovascular events: the number of stroke events and death;Lower extremity vascular assessment: degree of vascular stenosis, diabetic foot, amputation, death;Degree of diabetic retinopathy: non-proliferative phase, proliferative phase, blindness;Diabetic nephropathy: creatinine doubling, eGFR, dialysis frequency;Diabetic peripheral neuropathy: recovery of pain, numbness, and chills ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Glycosylated hemoglobin;Blood glucose;Blood uric acid;Blood lipids; | — |
Countries
China
Contacts
Public ContactZhao Xiyan
Outcome results
None listed